These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 11602339)
1. Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Abe T; Tohgi H; Murata T; Isobe C; Sato C Neurosci Lett; 2001 Oct; 312(3):177-9. PubMed ID: 11602339 [TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid. Mulder C; Wahlund LO; Blomberg M; de Jong S; van Kamp GJ; Scheltens P; Teerlink T J Neural Transm (Vienna); 2002 Sep; 109(9):1203-8. PubMed ID: 12203047 [TBL] [Abstract][Full Text] [Related]
3. Decrease in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in cerebrospinal fluid during elderly aging and in patients with sporadic form of amyotrophic lateral sclerosis. Isobe C; Abe T; Terayama Y Neurosignals; 2010; 18(1):43-8. PubMed ID: 20407287 [TBL] [Abstract][Full Text] [Related]
4. Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease. Arlt S; Schulze F; Eichenlaub M; Maas R; Lehmbeck JT; Schwedhelm E; Jahn H; Böger RH Dement Geriatr Cogn Disord; 2008; 26(1):58-64. PubMed ID: 18617736 [TBL] [Abstract][Full Text] [Related]
5. [The correlation of asymmetrical dimethylarginine level and oxidative stress to the onset of Alzheimer's disease]. Chen M; Jiang P; Lü J; Xiang ZH; Jiao BH Yao Xue Xue Bao; 2010 Aug; 45(8):1001-5. PubMed ID: 21351586 [TBL] [Abstract][Full Text] [Related]
6. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease. Selley ML Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048 [TBL] [Abstract][Full Text] [Related]
7. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons. Selley ML J Neurosci Res; 2004 Jul; 77(1):90-3. PubMed ID: 15197741 [TBL] [Abstract][Full Text] [Related]
8. L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients. Kuiper MA; Teerlink T; Visser JJ; Bergmans PL; Scheltens P; Wolters EC J Neural Transm (Vienna); 2000; 107(2):183-9. PubMed ID: 10847559 [TBL] [Abstract][Full Text] [Related]
9. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Tohgi H; Abe T; Yamazaki K; Murata T; Ishizaki E; Isobe C Neurosci Lett; 1999 Jul; 269(1):52-4. PubMed ID: 10821643 [TBL] [Abstract][Full Text] [Related]
10. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. Jung CS; Iuliano BA; Harvey-White J; Espey MG; Oldfield EH; Pluta RM J Neurosurg; 2004 Nov; 101(5):836-42. PubMed ID: 15543672 [TBL] [Abstract][Full Text] [Related]
11. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients. Hermenegildo C; Medina P; Peiró M; Segarra G; Vila JM; Ortega J; Lluch S J Clin Endocrinol Metab; 2002 Dec; 87(12):5636-40. PubMed ID: 12466365 [TBL] [Abstract][Full Text] [Related]
12. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805 [TBL] [Abstract][Full Text] [Related]
16. Endogenous inhibitors of nitric oxide and preeclampsia: a review. Slaghekke F; Dekker G; Jeffries B J Matern Fetal Neonatal Med; 2006 Aug; 19(8):447-52. PubMed ID: 16966108 [TBL] [Abstract][Full Text] [Related]
17. Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage. Martens-Lobenhoffer J; Sulyok E; Czeiter E; Büki A; Kohl J; Firsching R; Tröger U; Bode-Böger SM J Neurosci Methods; 2007 Aug; 164(1):155-60. PubMed ID: 17512604 [TBL] [Abstract][Full Text] [Related]
18. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression. Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027 [TBL] [Abstract][Full Text] [Related]
19. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. Selley ML J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938 [TBL] [Abstract][Full Text] [Related]
20. [ADMA (asymmetric dimethylarginine)--the inhibitor of nitric oxide (NO) synthesis: a new marker for vascular pathology]. Sela BA Harefuah; 2005 Sep; 144(9):655-9, 675, 674. PubMed ID: 16218539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]